Table 1 Patient information
| Â | RRMS | AQP4-Ab NMOSD | MOG-Ab |
|---|---|---|---|
Number of patients | 34 | 54 | 20 |
Age, mean (range), y | 41 (18–60) | 53 (22–83)*†| 39 (16–70) |
Gender, No. female (% female) | 25 (74) | 46 (85) | 9 (45) |
EDSS, median (range) | 4 (0–7) | 3 (0–8) | 2 (0–8) |
Disease duration, median (range), months | 89 (1–301) | 70 (3–270) | 16 (1–420)*~ |
Time since relapse, median (range), months | 23 (0–133) | 22 (0–108) | 8 (1–39)*~ |
On oral prednisolone, % | 0% | 85% | 35% |
On prednisolone, mean dose mg | 0 | 12 | 14 |
On azathioprine, % | 0 | 49 | 5 |
On methotrexate, % | 0 | 11 | 5 |
On mycophenolate, % | 0 | 19 | 5 |
On interferon β, % | 15 | 0 | 5 |
On glatiramer, % | 12 | 0 | 0 |
On fingolimod, % | 12 | 0 | 0 |
On dimethyl fumarate, % | 12 | 3 | 0 |
On natalizumab, % | 15 | 0 | 0 |